🇪🇺 Bevacizumab in European Union

EMA authorised Bevacizumab on 1 December 2005

Marketing authorisation

EMA — authorised 1 December 2005

  • Marketing authorisation holder: Roche Registration Limited
  • Status: approved

Bevacizumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Bevacizumab approved in European Union?

Yes. EMA authorised it on 1 December 2005.

Who is the marketing authorisation holder for Bevacizumab in European Union?

Roche Registration Limited holds the EU marketing authorisation.